Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Therapy of Normal Tension Glaucoma: Effects of Latanoprost and Bimatoprost on Ocular Hemodynamics

Zeitz O., Reuss J., Wiermann A., Matthiessen E. T., Richard G., Klemm M.
Dept. of Ophthalmology, Hamburg University

Purpose: Altered ocular perfusion is discussed as an important pathogenetic co-factor in primary open angle glaucoma and particular in normal tension glaucoma. The locally applied prostaglandine analogues bimatoprost and latanoprost are very effective for reduction of intraocular pressure (IOP). Little is known about the hemodynamic effects of these therapeutics.
Method: In a prospective, randomized and for the investigator blinded trial the effects of bimatoprost (Lumigan®) and latanoprost (Xalatan®) on intraocular pressure and ocular hemodynamics were studied. Therefore, the right eye of 21 patients with normal tension glaucoma were subjected to coulor Doppler imaging (CDI) shortly before and after a 3-5 weeks therapy with bimatoprost and latanoprost, respectively. For CDI a Siemens Elegra system with a 7.5L40 transducer was used.
Results: 10 patients were treated with latanoprost and 11 patients with bimatoprost. There was no significant difference in all measured quantities and glaucoma defining parameters between the both therapy groups prior to therapy. IOP was reduced by 3.2±1.1mmHg in presence of bimatoprost and by 2.8±1.5mmHg in presence of latanoprost (bimatoprost vs. latanoprost: n.s.). Peak systolic velocity, enddiastolic velocity, mean velocities as wells as resistance index in the central retinal artery, in short and


Zurück | Back